Morvan syndrome: A case report and review of the literature

Journal of Clinical Neuromuscular Disease

Volumn 13, Issue 4, 2012, Pages 214-227

  Abou Zeid, Elias ^a,b,c   Boursoulian, Lana Jeradeh ^a,b,c   Metzer, Walter S ^b,c   Gundogdu, Betul ^b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Morvan syndrome; myokymia; neuromytonia; voltage gated potassium channels antibodies

Indexed keywords

ADRENALIN; AZATHIOPRINE; CARBAMAZEPINE; CEFTRIAXONE; CYCLOPHOSPHAMIDE; DOXYCYCLINE; IMMUNOGLOBULIN; NORADRENALIN; PHENOXYBENZAMINE; PHENYTOIN; PREDNISONE; PROPRANOLOL; RITUXIMAB; VALPROIC ACID; VOLTAGE GATED POTASSIUM CHANNEL;

ADRENALIN BLOOD LEVEL; ADULT; AGGRESSION; AMNESIA; ANOREXIA; AUDITORY HALLUCINATION; AUTOIMMUNE DISEASE; AUTONOMIC DYSFUNCTION; BRAIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFABULATION; CONFUSION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ELECTROMYOGRAPHY; FEVER; FOLLOW UP; HUMAN; HYPERACTIVITY; HYPERHIDROSIS; HYPOTENSION; INFECTIOUS ARTHRITIS; INSOMNIA; JOINT SWELLING; LEG CRAMP; LEG ULCER; LITERATURE; MALE; MORVAN SYNDROME; MUSCLE TWITCH; MYOKYMIA; NERVE EXCITABILITY; NORADRENALIN BLOOD LEVEL; PHEOCHROMOCYTOMA; PLASMAPHERESIS; PRIORITY JOURNAL; PRURITUS; RASH; RECURRENT DISEASE; REVIEW; SWELLING; TENDON REFLEX; THYMECTOMY; THYMOMA; VISUAL HALLUCINATION;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CENTRAL NERVOUS SYSTEM; DATABASES, BIBLIOGRAPHIC; ELECTROMYOGRAPHY; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES; SYRINGOMYELIA; YOUNG ADULT;

EID: 84861852356     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e31822b1977     Document Type: Review

References (34)

1. Newsom-Davis J, Buckley C, Clover L, et al. Autoimmune disorders of neuronal potassium channels. Ann N Y Acad Sci. 2003;998:202-210.
2. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001;124: 2417-2426.
3. Rinaldi C, Russo CV, Filla A, et al. Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome. Neurol Sci. 2009;30:237-239.
4. Winger DI, Spiegler P, Trow TK, et al. Radiology-Pathology Conference: pulmonary hyalinizing gran-uloma associated with lupus-like anticoagulant and Morvan's Syndrome. Clin Imag. 2007;31:264-268.
5. Deymeer F, Akca S, Kocaman G, et al. fasciculations, autonomic symptoms and limbic encephalitis: a thy-moma-associated Morvan's-like syndrome. Eur Neurol. 2005;54:235-237.
6. Josephs KA, Silber MH, Fealey RD, et al. Neurophys-iologic studies in Morvan syndrome. J Clin Neuro-physiol. 2004;21:440-445.
7. Diaz-Manera J, Rojas-Garcia R, Gallardo E, et al. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol.2007;3:405-410.
8. Agius MA, Zhu S, Lee EK, et al. Antibodies to AChR, synapse-organizing proteins, titin, and other muscle proteins in Morvan's fibrillary chorea. Ann N YAcad Sci. 1998 ;841:522-524.
9. Vernay D, Dubost JJ, Thevenet JP, et al. 'Choree fibrillaire de Morvan' followed by Guillain-Barre syndrome in a patient receiving gold therapy. Arthritis Rheum. 1986;29:1413-1414.
10. Iwasaki Y, Kinoshita M, Ikeda K, et al. Concurrence of myasthenia gravis and choree fibrillaire de Morvan. Eur Arch Psychiatry Neurol Sci. 1990; 239:335-336.
11. Toosy AT, Burbridge SE, Pitkanen M, et al. Functional imaging correlates of fronto-temporal dysfunction in Morvan's syndrome. J Neurol Neurosurg Psychiatry. 2008;79:734-735.
12. Bajaj BK, Shrestha S. An interesting case report of Morvan's syndrome from the Indian subcontinent. Neurol India. 2007;55:67-69.
13. Haug BA, Schoenle PW, Karch BJ, et al. Morvan's fibrillary chorea. A case with possible manganese poisoning. Clin Neurol Neurosurg. 1989;91:53-59.
14. Maselli RA, Agius M, Lee EK, et al. Morvan's fibrillary chorea. Electrodiagnostic and in vitro microelec-trode findings. Ann N Y Acad Sci. 1998;841: 497-500.
15. Lee EK, Maselli RA, Ellis WG, et al. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry. 1998; 65:857-862.
16. Madrid A, Gil-Peralta A, Gil-Neciga E, et al. Morvan's fibrillary chorea: remission after plasmapheresis. J Neurol. 1996;243:350-353.
17. Barber PA, Anderson NE, Vincent A. Morvan's syndrome associated with voltage-gated K+ channel antibodies. Neurology. 2000;54:771-772.
18. Loscher WN, Wanschitz J, Reiners K, et al. Morvan's syndrome: clinical, laboratory, and in vitro electro-physiological studies. Muscle Nerve. 2004;30: 157-163.
19. Evoli A, Lo Monaco M, Marra R, et al. Multiple paraneoplastic diseases associated with thymoma. Neuromuscul Disord. 1999;9:601-603.
20. Halbach M, Homberg V, Freund HJ. Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody. J Neurol. 1987;234: 433-436.
21. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004 ;127:701-712.
22. Hudson LA, Rollins YD, Anderson CA, et al. Reduplicative paramnesia in Morvan's syndrome. J Neurol Sci. 2008;267:154-157.
23. Antozzi C, Frassoni C, Vincent A, et al. Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology. 2005; 64:1290-1293.
24. Goldberg RJ. Sound-alike syndromes: first report of Morvan's, and not Marfan's, syndrome. J Am Geriatr Soc. 2008;56:774-776.
25. Cottrell DA, Blackmore KJ, Fawcett PR, et al. Sub-acute presentation of Morvan's syndrome after thymectomy. J Neurol Neurosurg Psychiatry. 2004; 75:1504-1505.
26. Rueff L, Graber JJ, Bernbaum M, et al. Voltage-gated potassium channel antibody-mediated syndromes: a spectrum of clinical manifestations. Rev Neurol Dis. 2008;5:65-72.
27. Shillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol. 1995;38:714-722.
28. Arimura K, Sonoda Y, Watanabe O, et al. Issacs' syndrome as a potassium channelopathy of the nerve. Muscle Nerve. 2002;Suppl 11:S55-58.
29. Kleopa KA, Elman LB, Lang B, et al. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain. 2006;129:1570-1584.
30. Cavany JA, Chaignot A. Accidents nerveux de la chrysotherapie. Presse Med. 1934;42:478.
31. Katrak SM, Pollock M, O'Brien CP, et al. Clinical and morphological features of gold neuropathy. Brain. 1980;103:671-693.
32. Hazelwood JC, Stefan GE, Bowen JM. Motor unit irritability in beagles before and after exposure to cholinesterase inhibitors. Am J Vet Res. 1979;40: 852-856.
33. Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 2008;10:131-137.
34. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010;133:2734-2748.